These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9000780)

  • 1. Case study: adverse effects of smoking marijuana while receiving tricyclic antidepressants.
    Wilens TE; Biederman J; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):45-8. PubMed ID: 9000780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: adverse effects of taking tricyclic antidepressants and smoking marijuana.
    Mannion V
    Can Fam Physician; 1999 Nov; 45():2683-4. PubMed ID: 10587776
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
    Pediatrics; 1996 Aug; 98(2 Pt 1):301-4. PubMed ID: 8692637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic medication in children and the QT interval: case report and discussion.
    Alderton HR
    Can J Psychiatry; 1995 Aug; 40(6):325-9. PubMed ID: 7585402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
    Wilens TE; Biederman J; Spencer T; Geist DE
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nortriptyline in the treatment of ADHD: a chart review of 58 cases.
    Wilens TE; Biederman J; Geist DE; Steingard R; Spencer T
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):343-9. PubMed ID: 8444763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic antidepressant treatment of children with ADHD and tic disorders.
    Spencer T; Biederman J; Wilens T
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1203-4. PubMed ID: 7982871
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of imipramine hydrochloride on the EEG of children with Attention-Deficit/Hyperactivity Disorder who are non-responsive to stimulants.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Johnstone SJ
    Int J Psychophysiol; 2008 Jun; 68(3):186-92. PubMed ID: 18304665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and treatment of attention deficit disorder.
    Bond WS
    Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacology of ADHD in adolescents.
    Greydanus DE; Sloane MA; Rappley MD
    Adolesc Med; 2002 Oct; 13(3):599-624. PubMed ID: 12270803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of imipramine-associated immune thrombocytopenia.
    Aksoy A; Erduran E; Gedik Y
    Turk J Pediatr; 2009; 51(3):275-8. PubMed ID: 19817272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
    Conforti D; Borgherini G; Fiorellini Bernardis LA; Magni G
    Int Clin Psychopharmacol; 1999 May; 14(3):197-8. PubMed ID: 10435776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants in the treatment of children with attention deficit disorder.
    Pliszka SR
    J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008
    [No Abstract]   [Full Text] [Related]  

  • 15. [Withdrawal syndrome from antidepressive drugs. Report of 5 cases].
    Lejoyeux M; Rodière-Rein C; Adès J
    Encephale; 1992; 18(3):251-5. PubMed ID: 1299596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
    Spencer T; Biederman J; Wilens T; Steingard R; Geist D
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):205-10. PubMed ID: 8428873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathophysiology, medical management, and dental implications of children and young adults having attention-deficit hyperactivity disorder.
    Friedlander AH; Yagiela JA; Paterno VI; Mahler ME
    J Calif Dent Assoc; 2003 Sep; 31(9):669-78. PubMed ID: 14560871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the prevalence of chronic medication use in children: 2002-2005.
    Cox ER; Halloran DR; Homan SM; Welliver S; Mager DE
    Pediatrics; 2008 Nov; 122(5):e1053-61. PubMed ID: 18977954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.